Trial Skin Cancer Vaccine Dramatically Reduced Melanoma Relapse in Patients Receiving Immunotherapy
A personalized skin cancer vaccine has almost halved the risk of death or relapse in patients with the deadliest form of melanoma. The trial involved men and women who had surgery to remove melanoma from lymph nodes or other organs and were at high risk of the disease returning. About 1.3…
Read more